Tower Research Capital LLC (Trc) Werewolf Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 23,767 shares of HOWL stock, worth $50,386. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,767
Previous 10,537
125.56%
Holding current value
$50,386
Previous $68,000
16.18%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding HOWL
# of Institutions
72Shares Held
32.2MCall Options Held
53.8KPut Options Held
1.3K-
Ra Capital Management, L.P. Boston, MA6.14MShares$13 Million0.23% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.28MShares$9.08 Million5.74% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.24MShares$6.87 Million0.41% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.39MShares$5.06 Million0.94% of portfolio
-
Bank Of America Corp Charlotte, NC2.15MShares$4.55 Million0.0% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $62.6M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...